Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Apr;44(4):703-709.
doi: 10.1002/jum.16632. Epub 2024 Dec 12.

Sonographic Characterization of Red-Blue Neurofibromas in Patients With Neurofibromatosis Type 1: An Observational Prospective Study

Affiliations
Observational Study

Sonographic Characterization of Red-Blue Neurofibromas in Patients With Neurofibromatosis Type 1: An Observational Prospective Study

Inés Oteiza-Rius et al. J Ultrasound Med. 2025 Apr.

Abstract

Objectives: Red-blue neurofibromas (RBNs), found in up to 29% of adult neurofibromatosis type 1 (NF1) patients, present as red-blue macules measuring 1-2 cm in diameter, primarily on the trunk. Despite their prevalence, RBNs often go unnoticed due to their subtle appearance. Ultrasound characterization serves as a diagnostic clue yet lacks comprehensive studies in both adult and pediatric populations. This study aims to define and compare RBNs' prevalence, characteristics, and ultrasound features in adult and pediatric patients with NF1.

Methods: This prospective study involved 118 patients (92 pediatric patients and 26 adults) diagnosed with NF1. Clinical examinations combined with cutaneous ultrasound scans using linear multifrequency probes (L4-12t, L10-22, ML6-15, or L8-18 MHz) were performed in order to determine the prevalence, and clinical and sonographic characteristics of RBN in both populations. Statistical analyses were performed using t tests and chi-square tests.

Results: RBNs were found in 26.3% (31) of the patients after clinical examination, including 179 lesions. RBN prevalence differed significantly between pediatric (10.9%) and adult (66.7%) patients. Lesions were primarily on the trunk and exhibited similar clinical characteristics. Ultrasound reveals RBNs as hypoechoic, oval lesions with irregular borders. Our results show that pediatric RBNs are typically more superficial and hypoechogenic, while adult RBNs are deeper and more heterogeneous.

Conclusion: Ultrasound findings showed subtle differences in lesion depth, morphology, and echogenicity between these 2 age-related groups. These changes highlight ultrasound's role in identifying RBNs in patients with NF1 and monitoring their evolution.

Keywords: childhood; cutaneous; neurofibroma; neurofibromatosis 1; red blue macules; ultrasound.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical images of RBNs (arrowheads) in (A) the left shoulder of a pediatric patient and in (B) the right thoracic region in an adult patient.
Figure 2
Figure 2
Sonography scans with L10–22 and 4–12t MHz linear probes of RBNs, respectively, in (A) a 14‐year‐old female showing well‐defined, oval‐shaped, hypoechoic dermal lesion and (B) a 43‐year‐old patient showing a dermo‐hypodermal heteroechogenic lesion with type I vascularization in power Doppler.
Figure 3
Figure 3
(A) Ultrasound with a 10–22 MHz linear probe showing a dermal hypoechoic lesion is evident, with posterior acoustic enhancement in a pediatric patient. (B) Power Doppler ultrasound with a 10–22 MHz linear probe showing a dermal heteroechogenic lesion with peripheral and intralesional vascularization observed in power Doppler mode in an adult patient. (C and D) Histopathological images (hematoxylin and eosin, 40X) showing vessels and trapped follicles and sebaceous glands located in the stroma of the RBN, which correlate with ultrasound findings.

Similar articles

References

    1. Hernández‐Martín A, Duat‐Rodríguez A. An update on neurofibromatosis type 1: not just café‐au‐lait spots, freckling, and neurofibromas. An update. Part I. Dermatological clinical criteria diagnostic of the disease. Actas Dermosifiliogr 2016; 107:454–464. 10.1016/j.ad.2016.01.004. - DOI - PubMed
    1. García‐Martínez FJ, Alfageme F, Duat‐Rodríguez A, Andrés Esteban EM, Hernández‐Martín A. Clinical and sonographic classification of neurofibromas in children with neurofibromatosis type 1—a cluster analysis. Ultraschall Med 2023; 44:e118–e125. 10.1055/a-1640-9621. - DOI - PubMed
    1. Bergqvist C, Fertitta L, Ezzedine K, et al. Identification of three clinical neurofibromatosis 1 subtypes: latent class analysis of a series of 1351 patients. J Eur Acad Dermatol Venereol 2022; 36:739–743. 10.1111/jdv.17974. - DOI - PubMed
    1. Duong TA, Bastuji‐Garin S, Valeyrie‐Allanore L, Sbidian E, Ferkal S, Wolkenstein P. Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross‐sectional study of 728 patients. Dermatology 2011; 222:269–273. 10.1159/000327379. - DOI - PubMed
    1. Vabres P, de Lonlay P, Amiel J, Lyonnet S, Munnich A, de Prost Y. Angiomatous and cerulodermic macules: early cutaneous signs of neurofibromatosis type I. Ann Dermatol Venereol 1998; 125:593–594. - PubMed

Publication types